Literature DB >> 23663920

Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy.

Berend J van Welzen, Karel J van Erpecum, Pieter-Jan A Haas, Fiebo J ten Kate, Tania Mudrikova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23663920     DOI： 10.1016/j.clinre.2013.03.008

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  3 in total

Review 1.  Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?

Authors:  Laura Elena Carreto-Binaghi; Lisandra Serra Damasceno; Nayla de Souza Pitangui; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Rosely Maria Zancopé-Oliveira; Maria Lucia Taylor
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

Review 2.  Cholestasis and disseminated histoplasmosis in a psoriatic patient on infliximab: case report and review of literature.

Authors:  Steven Park; Janice Cheong; Kaitlin Kyi; Jose Aranez; Sohaib Abu-Farsakh; Christa Whitney-Miller; Bandar Al-Judaibi; Marie Laryea
Journal:  BMC Gastroenterol       Date:  2020-05-08       Impact factor: 3.067

3.  Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod.

Authors:  Aleksandra A Abrahamowicz; Eric J Chow; Daniel D Child; Alexander Dao; Elizabeth D Morrison; Sharon K Gill; David M Rogers; Kanishka Garvin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.